AU Stock MarketDetailed Quotes

PAR Paradigm Biopharmaceuticals Ltd

Watchlist
  • 0.295
  • 0.0000.00%
20min DelayNot Open Jul 4 16:00 AET
103.36MMarket Cap-1648P/E (Static)

Paradigm Biopharmaceuticals Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Paradigm Biopharmaceuticals Ltd Earnings Date

Currency: AUD

Period

H1 FY2024 Earnings

--

EPS(YoY)

-0.16

-48.71%
Net Income(YoY)

-48.96M

-53.63%
Analyst Rating

Strong Buy

May 28, 2024

Paradigm Biopharmaceuticals Ltd Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: AUD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2023/FY46.760K / 10.000K--
--2022/FY79.220K / ----
--2021/FY8.942M / 3.400M--
--2020/FY4.695M / 2.625M--
--2019/FY3.246M / 3.000M--
DatePeriodRevenue/EstimateEarnings Call
--2023/FY46.760K / 10.000K--
--2022/FY79.220K / ----
--2021/FY8.942M / 3.400M--
--2020/FY4.695M / 2.625M--
--2019/FY3.246M / 3.000M--

Unlock Free Earnings Estimates

Paradigm Biopharmaceuticals Ltd Earnings Reports

  • Paradigm Biopharmaceuticals Ltd: Half Yearly Report and Accounts

    Feb 27 20:15 ET

  • Paradigm Biopharmaceuticals Ltd: 2023 Annual Report and Appendix 4E

    Aug 25, 2023 01:53 ET

  • Paradigm Biopharmaceuticals Ltd: Half Yearly Report and Accounts

    Feb 26, 2023 17:57 ET

  • Paradigm Biopharmaceuticals Ltd: 2022 Annual Report and Appendix 4E

    Aug 25, 2022 18:57 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: May 28, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    AU
    Overall
    Symbol
    Latest Price
    %Chg